Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Erratum to: Per-capita consumption of analgesics: a nine-country survey over 20 years

  • The original article was published in The Journal of Headache and Pain 2008 9:46

Erratum to: J Headache Pain DOI 10.1007/s10194-008-0046-6

This article unfortunately contained errors in two places.

1. The two columns of data in Table 1 were under the wrong headings. The correct version of Table 1 is given here:

Table 1 Relative proportions of standardised medication units (SU) among different countries comparing weighted and unweighted proportions

2. Incorrect percentages were given in the last paragraph of the “Results” section, immediately before the “Discussion”. The corrected paragraph is as follows:

In 2005 in the prescription (Rx) group of N2B analgesics, combination products accounted for approx. 33% of all Rx analgesics in terms of SU. The most important combinations are tilidine plus naloxone (14% of all SU in the Rx group), followed by codeine plus paracetamol (12%). The predominating single products in the Rx group are metamizole (36%) and tramadol (21%). Growth in the Rx group can be seen for both the combinations named and the single products.

Author information

Correspondence to H.-C. Diener.

Additional information

The online version of the original article can be found under doi:10.1007/s10194-008-0046-6.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Diener, H., Schneider, R. & Aicher, B. Erratum to: Per-capita consumption of analgesics: a nine-country survey over 20 years. J Headache Pain 9, 337 (2008).

Download citation


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.